Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that address emerging targets in oncology, provided an update on clinical progress and ...

Bio announced ongoing Phase 2 trial for obesity currently enrolling with U.S. patient cohort to be added in 2025 and positive ...

Previously reported Honeycomb topline results showed radiprodil was generally well-tolerated; A key secondary analysis demonstrated a median reduction of 86% in countable motor se ...

Meeting & Exposition of the American Society of Hematology (ASH) will take place in San Diego, Calif. and online Dec. 7-10. Improving access to life-saving therapies for blood disorders is the theme ...

We're nearing the end of Phase 5 of the MCU which marks the midway point of The Multiverse Saga, following the releases of Agatha All Along and Deadpool & Wolverine. If that all sounds confusing ...

Cassava Sciences' Phase 3 trial for Alzheimer's failed to ... and that simufilam binds to altered filamin A in order to fix aberrant signaling caused by altered filamin A. Misfolded filamin ...

You’ve reached your account maximum for followed topics. A recent Diablo 4 patch significantly boosted the drop rate of Aberrant Cinders. One player managed to earn a whopping 5,858 Aberrant ...

The mid-season patch for Diablo 4 Season 6 gave a major boost to Aberrant Cinder drops and players are terrified of a nerf. The big talking points of the mid-season update are the Welcome Back ...

Azafaros B.V., a clinical-stage biotechnology company focused on rare diseases and lysosomal storage disorders, today announced that advancements with its lead asset, nizubaglustat, will feature ...